Premium
PD‐1 BLOCKADE IN A FRENCH SERIES OF 13 RELAPSED / REFRACTORY NK/T‐CELL LYMPHOMA PATIENTS
Author(s) -
Couronné L.,
Chaubard S.,
Bruneau J.,
Laurent C.,
Rossignol J.,
Suarez F.,
Moignet Autrel A.,
Clavert A.,
Duléry R.,
Alexis M.,
Lemonnier F.,
Noël R.,
Tardy S.,
Gaulard P.,
Fataccioli V.,
Kataoka K.,
Ghesquières H.,
Salles G.,
Bachy E.,
Hermine O.,
Jaccard A.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.83_2630
Subject(s) - medicine , lymphoma , t cell lymphoma , pembrolizumab , immunotherapy , regimen , gastroenterology , oncology , immune system , immunology